Serum and Urinary Biomarkers in COVID-19 Patients with or without Baseline Chronic Kidney Disease.

COVID-19 CT severity score IL-6 acute kidney injury biomarkers chronic kidney disease mortality uKIM1 uNGAL

Journal

Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269

Informations de publication

Date de publication:
22 Feb 2023
Historique:
received: 06 02 2023
revised: 20 02 2023
accepted: 21 02 2023
medline: 30 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: epublish

Résumé

In a prospective, observational, non-interventional, single-center study, we assessed various plasma and urinary biomarkers of kidney injury (neutrophil gelatinase-associated Lipocain [NGAL], kidney-injury molecule-1 [KIM-1], and interleukin-18 [IL-18]); inflammation (IL-6, C-reactive protein [CRP]); plus angiotensin converting enzyme 2 (ACE2) in 120 COVID-19 patients (of whom 70 had chronic kidney disease (CKD) at emergency-department (ED) admission). Our aim was to correlate the biomarkers with the outcomes (death, acute kidney injury [AKI]). All patients had received a chest-CT scan at admission to calculate the severity score (0-5). Biomarkers were also assessed in healthy volunteers and non-COVID-19-CKD patients. These biomarkers statistically differed across subgroups, i.e., they were significantly increased in COVID-19 patients, except for urinary (u)KIM1 and uIL-18. Amongst the biomarkers, only IL-6 was independently associated with mortality, along with AKI and not using remdesivir. Regarding the prediction of AKI, only IL-6 and uKIM1 were significantly elevated in patients presenting with AKI. However, AKI could not be predicted. Having high baseline IL-6 levels was associated with subsequent ventilation requirement and death. The mortality rate was almost 90% when the chest CT-scan severity score was 3 or 4 vs. 6.8% when the severity score was 0-2 (

Identifiants

pubmed: 36983566
pii: jpm13030382
doi: 10.3390/jpm13030382
pmc: PMC10051063
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Ren Fail. 2022 Dec;44(1):1717-1731
pubmed: 36259446
Am J Respir Crit Care Med. 2020 Sep 15;202(6):786-787
pubmed: 32640167
N Engl J Med. 2022 Jan 27;386(4):305-315
pubmed: 34937145
Kidney360. 2021 May 18;2(7):1095-1106
pubmed: 35368365
Nat Rev Dis Primers. 2021 Jul 15;7(1):52
pubmed: 34267223
Front Med (Lausanne). 2022 Apr 04;9:705908
pubmed: 35445048
Radiology. 2020 Aug;296(2):E86-E96
pubmed: 32301647
Kidney Int. 2020 Aug;98(2):294-309
pubmed: 32709292
Pathogens. 2022 Feb 01;11(2):
pubmed: 35215138
Acta Anaesthesiol Scand. 2021 Mar;65(3):364-372
pubmed: 33190222
Virol J. 2021 Jun 4;18(1):117
pubmed: 34088317
Biomark Insights. 2022 Jun 16;17:11772719221106600
pubmed: 35747885
Caspian J Intern Med. 2022;13(Suppl 3):228-235
pubmed: 35872679
Chest. 2021 Mar;159(3):1126-1135
pubmed: 33271157
J Am Geriatr Soc. 2020 May;68(5):926-929
pubmed: 32255507
Eur Radiol. 2020 Nov;30(11):6170-6177
pubmed: 32518989
Acta Physiol (Oxf). 2017 Mar;219(3):554-572
pubmed: 27474473
Clin Chim Acta. 2022 Nov 1;536:135-141
pubmed: 36150522
Research (Wash D C). 2020 Apr 19;2020:2402961
pubmed: 32377638
Front Med (Lausanne). 2022 Mar 18;9:799298
pubmed: 35372447
J Am Soc Nephrol. 2021 Jan;32(1):2-4
pubmed: 33037129
J Pers Med. 2022 Oct 09;12(10):
pubmed: 36294815
Curr Opin Crit Care. 2022 Dec 1;28(6):630-637
pubmed: 36194146
Chest. 2021 Aug;160(2):652-670
pubmed: 33861993
Clin Biochem. 2022 Apr;102:1-8
pubmed: 35093314
Diagnostics (Basel). 2022 Aug 26;12(9):
pubmed: 36140474
Infection. 2022 Feb;50(1):27-41
pubmed: 34331674
J Allergy Clin Immunol. 2020 Jul;146(1):128-136.e4
pubmed: 32425269
Ann Intensive Care. 2020 Sep 3;10(1):117
pubmed: 32880774
Am J Kidney Dis. 2021 Dec;78(6):804-815
pubmed: 34364906
Kidney Int Rep. 2021 Dec;6(12):2979-2992
pubmed: 34642645
Crit Care. 2020 Oct 12;24(1):605
pubmed: 33046113
Am J Kidney Dis. 2022 Feb;79(2):257-267.e1
pubmed: 34710516
Kidney Int. 2020 Jul;98(1):209-218
pubmed: 32416116
Am J Kidney Dis. 2020 Dec;76(6):826-841.e1
pubmed: 32679151
Nat Rev Nephrol. 2020 Feb;16(2):69-70
pubmed: 31848461
Pediatr Res. 2023 Feb;93(3):654-660
pubmed: 35681092
Lancet. 2022 May 21;399(10339):1941-1953
pubmed: 35512728

Auteurs

Rumen Filev (R)

Department of Nephrology, Internal Disease Clinic, University Hospital "Saint Anna", 1750 Sofia, Bulgaria.
Faculty of Medicine, Medical University Sofia, 1504 Sofia, Bulgaria.

Mila Lyubomirova (M)

Department of Nephrology, Internal Disease Clinic, University Hospital "Saint Anna", 1750 Sofia, Bulgaria.
Faculty of Medicine, Medical University Sofia, 1504 Sofia, Bulgaria.

Julieta Hristova (J)

Faculty of Medicine, Medical University Sofia, 1504 Sofia, Bulgaria.
Department of Clinical Laboratory, University Hospital "Alexandrovska", 1431 Sofia, Bulgaria.

Boris Bogov (B)

Department of Nephrology, Internal Disease Clinic, University Hospital "Saint Anna", 1750 Sofia, Bulgaria.
Faculty of Medicine, Medical University Sofia, 1504 Sofia, Bulgaria.

Krassimir Kalinov (K)

Head Biometrics Group, Comac-Medical Ltd., 1404 Sofia, Bulgaria.

Dobrin Svinarov (D)

Faculty of Medicine, Medical University Sofia, 1504 Sofia, Bulgaria.
Department of Clinical Laboratory, University Hospital "Alexandrovska", 1431 Sofia, Bulgaria.

Lionel Rostaing (L)

Nephrology, Hemodialysis, Apheresis and Kidney Transplantation Department, Grenoble University Hospital, 38043 Grenoble, France.
Medicine Faculty, University of Grenoble Alpes, 38000 Grenoble, France.

Classifications MeSH